Brainlab has purchased the surgical robotics technology provider for an undisclosed amount, two years after investing in the company.

BioLeaders is investing $10m in an as yet unnamed spinout from Weizmann Institute of Science working on a genetic drug for cancer.

The former head of Johnson & Johnson's JLabs@TMC incubator has been appointed director of Texas Medical Center's TMC Innovation Institute.

Busy Burr, a founding partner of Humana Health Ventures who featured on GCV’s 2017 and 2018 Powerlists, was named a director at Mr Cooper at the end of February.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The funding will be funnelled into an unnamed p53 suppressor-focused oncology Weizmann spinout and ultrasound guidance device maker On-Sight Medical.

KU Leuven has generated 60 spinouts since 2000, the most of any Flemish region university, while digital-focused research centre IMinds topped the bill for Flemish strategic institutes.

Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.

Sherlock Biosciences will develop molecular diagnostics tools co-developed by researchers at Harvard University and Broad Institute, including Crispr inventor Feng Zhang.

University of Dundee intelligent drug design spinout Exscientia has struck a business deal with Celgene after raising series B funding from the corporate in January.